Journal: Bone Research
Article Title: Neuronal guidance factor Sema3A inhibits neurite ingrowth and prevents chondrocyte hypertrophy in the degeneration of knee cartilage in mice, monkeys and humans
doi: 10.1038/s41413-024-00382-0
Figure Lengend Snippet: The platelet-rich plasma (PRP) containing Sema3A injection rescues knee cartilage during the normal degenerative process in OA patients. a Orthotopic (AP) and lateral (LAT) view of X-ray images of the knee at pre-injection and post-injection (Hidden in the picture is the patient’s private information). b Kellgren–Lawrence analysis of the joint space between control ( n = 10 individuals) and experiment ( n = 10 individuals) groups. Analysis of Variance (ANOVA) with LSD Post Hoc test was used for statistical analysis. The PRP treatment (Pre-treatment: KL, 2.00; 95% confidence interval [CI], 1.50–2.50. Post-treatment: KL, 2.00; 95% CI, 1.50–2.50), HA control group (Pre-treatment: KL, 1.90; 95% CI, 1.50–2.30. Post-treatment: KL, 1.90; 95% CI, 1.50–2.30). c Quantitative T2-weighted MRI scan of the knee cartilage, red parts show soft tissue in the knee joint. d Quantitative analysis of the ROI in T2 value between control ( n = 10 individuals) and experiment ( n = 10 individuals) groups. The PRP treatment group (Pre-treatment: Quantitative MRI ROI, 122.610; 95% CI, 75.509–183.659. Post-treatment: Quantitative MRI ROI, 145.490; 95% CI, 92.289–210.238). The HA control group (Pre-treatment: Quantitative MRI ROI, 63.680; 95% CI, 52.701–76.570. Post-treatment: Quantitative MRI ROI, 80.030; 95% CI, 64.964–98.677). Analysis of Variance (ANOVA) with LSD Post Hoc test was used for statistical analysis. A representative result from nine independent experiments is shown. e – h Gait analysis of the control group ( n = 10 individuals) and experimental group ( n = 10 individuals). e The walking speed of the PRP treatment group (Pre-treatment: Speed, 0.917; 95% CI, 0.850–0.980. Post-treatment: Speed, 1.089; 95% CI, 1.001–1.182) and HA control group (Pre-treatment: Speed, 0.984; 95% CI, 0.846–1.098. Post-treatment: Speed, 1.015; 95% CI, 0.943–1.088). f The Moment max of HA control group (Pre-treatment: Moment max, 0.303; 95% CI, 0.212–0.404. Post-treatment: Moment max, 0.329; 95% CI, 0.235–0.436) a little bit higher than the PRP treatment group (Pre-treatment: Moment max, 0.312; 95% CI, 0.223–0.427. Post-treatment: Moment max, 0.333; 95% CI, 0.272–0.397). g , h The Gait analysis of the PRP treatment group and HA control group. i Pain analysis between control ( n = 10 individuals) and experimental ( n = 10 individuals) groups. PRP treatment group (Pre-treatment: VAS score, 30.60; 95% CI, 21.11–40.40. Post-treatment: VAS score, 12.95; 95% CI, 9.45–17.05) had a higher reduction of pain than the HA control group (Pre-treatment: VAS score, 28.50; 95% CI, 21.20–36.40. Post-treatment: VAS score, 13.90; 95% CI, 11.00–17.40). Analysis of Variance (ANOVA) with LSD Post Hoc test was used for statistical analysis. All data are reported as the mean ± SD
Article Snippet: These animals received knee injection under anesthesia following approval from the Ethical Review Board of West China Hospital Sichuan University (No. 2018147A) and were divided into three groups: intra-articular injection of Hyaluronate acid (mean Mol. wt: 0.8~1.2 million, ARTZ @ Dispo, JP), Sema3A protein (R&D SYSTEMS, 2150-S3) and lentivirus Rlv-CMV-sema3a-Efla-EGFP (BrainVTA, Wuhan, China) ( n = 12, 4 monkeys in each group, 2 knees tested per monkey).
Techniques: Clinical Proteomics, Injection, Control